A company seeks your input regarding development of a fast-acting bowel movement therapy for individuals who have neurogenic bowel dysfunction (i.e., an inability to defecate when desired due to neurological conditions such as spinal cord injury, multiple sclerosis, spina bifida, Parkinson’s disease, etc.). The goal of the new therapy is to be more convenient, predictable, and effective than laxatives, stimulant suppositories, enemas and manual bowel programs.

We value your opinion and ask you to complete an anonymous, 10-minute survey that will help guide the design of new treatments for defecation disorders. The survey asks about medical conditions and if relevant, current bowel management practices. A proposed drug product is then described, followed by questions about preferences for its use and administration.

Participation is anonymous and completely voluntary. To participate in the survey, you must be 18 years or older and be an individual with neurogenic bowel dysfunction or a caretaker of someone experiencing neurogenic bowel dysfunction.  If uncomfortable, participants may skip questions regarding their current bowel management program, but we request questions regarding basic background and questions about the proposed drug product be answered.

Data collected is for internal use only, will guide us in developing therapies that will be most helpful for you.

Thank you for participating.

 For more information or questions, please feel free to email: makatofiasc@yahoo.com